Loxo Oncology Backtesting

Loxo Oncology Inc -- USA Stock  

USD 89.28  0.1  0.11%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Loxo Oncology Inc and determine expected loss or profit from investing in Loxo Oncology over given investment horizon. Please see also Loxo Oncology Hype Analysis, Loxo Oncology Correlation, Loxo Oncology Valuation, Loxo Oncology Volatility as well as analyze Loxo Oncology Alpha and Beta and Loxo Oncology Performance
Investment Horizon     30 Days    Login   to change

Loxo Oncology 'What if' Analysis

September 17, 2017
No Change 0.00  0.0%
In 31 days
October 17, 2017
If you would invest  0.00  in Loxo Oncology on September 17, 2017 and sell it all today you would earn a total of 0.00 from holding Loxo Oncology Inc or generate 0.0% return on investment in Loxo Oncology over 30 days. Loxo Oncology is related to or competes with NantKwest, Del Mar, Dimension Therapeutics, VBI Vaccines, Vascular Biogenics, and Vericel. Loxo Oncology Incs lead product candidate comprises LOXO101 an oral and selective inhibitor of tropomyosin receptor kina...

Loxo Oncology Upside/Downside Indicators


Loxo Oncology Market Premium Indicators

Loxo Oncology Inc lagged returns against current returns

 Current and Lagged Values 

Loxo Oncology regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Loxo Oncology Inc Backtested Returns

We consider Loxo Oncology not too volatile. Loxo Oncology Inc has Sharpe Ratio of 0.0132 which conveys that Loxo Oncology Inc had 0.0132% of return per unit of risk over the last 1 month. Our philosophy towards estimating volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Loxo Oncology which you can use to evaluate future volatility of the firm. Please verify Loxo Oncology Inc Downside Deviation of 1.56, Mean Deviation of 1.92 and Risk Adjusted Performance of 0.0192 to check out if risk estimate we provide are consistent with the epected return of 0.0441%. Loxo Oncology has performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of 0.3929 which conveys that as returns on market increase, Loxo Oncology returns are expected to increase less than the market. However during bear market, the loss on holding Loxo Oncology will be expected to be smaller as well.. Although it is extremely important to respect Loxo Oncology Inc price patterns, it is better to be realistic regarding the information on equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Loxo Oncology Inc technical indicators you can presently evaluate if the expected return of 0.0441% will be sustainable into the future. Loxo Oncology Inc right now secures a risk of 3.3417%. Please verify Loxo Oncology Inc Standard Deviation as well as the relationship between Value At Risk and Kurtosis to decide if Loxo Oncology Inc will be following its current price movements.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.47) 

Modest reverse predictability

Loxo Oncology Inc has modest reverse predictability. Overlapping area represents the amount of predictability between Loxo Oncology time series from September 17, 2017 to October 2, 2017 and October 2, 2017 to October 17, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Loxo Oncology Inc price movement. The serial correlation of -0.47 indicates that about 47.0% of current Loxo Oncology price fluctuation can be explain by its past prices. Given that Loxo Oncology Inc has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Loxo Oncology for similar time interval.
Correlation Coefficient -0.47
Spearman Rank Test -0.49
Price Variance 3.4
Lagged Price Variance 10.03

Loxo Oncology Lagged Returns

 Regressed Prices 

Loxo Oncology Performance vs DOW

The median price of Loxo Oncology for the period between Sun, Sep 17, 2017 and Tue, Oct 17, 2017 is 89.52 with a coefficient of variation of 3.06. The daily time series for the period is distributed with a sample standard deviation of 2.73, arithmetic mean of 89.18, and mean deviation of 2.06. The Stock did not receive any noticable media coverage during the period.
Price Growth (%)